1. Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats.
- Author
-
Li J, Kaneko T, Wang Y, Qin LQ, Wang PY, and Sato A
- Subjects
- Acetaminophen administration & dosage, Administration, Oral, Animals, Carbon Tetrachloride administration & dosage, Chemical and Drug Induced Liver Injury metabolism, Chromans administration & dosage, Cytochrome P-450 CYP3A, Diabetes Mellitus, Type 2 metabolism, Diet, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Synergism, Enzyme Induction, Hypoglycemic Agents administration & dosage, Injections, Intraperitoneal, Male, Rats, Rats, Mutant Strains, Rats, Wistar, Thiazoles administration & dosage, Troglitazone, Acetaminophen toxicity, Aryl Hydrocarbon Hydroxylases, Chemical and Drug Induced Liver Injury pathology, Chromans pharmacology, Cytochrome P-450 Enzyme System biosynthesis, Hypoglycemic Agents pharmacology, Oxidoreductases, N-Demethylating biosynthesis, Thiazoles pharmacology, Thiazolidinediones
- Abstract
Troglitazone (TRZ) is the first of a new group of oral antidiabetic drugs, the thiazolidinediones, and is proven to lower plasma glucose levels in patients with type 2 diabetes mellitus. However, the concern has been raised because of several reports, in which severe hepatic dysfunction leading to hepatic failure was demonstrated in a few patients receiving the drug. We studied the effects of TRZ on the hepatotoxicity of carbon tetrachloride (CCl(4)) and acetaminophen (APAP) in rats, both of which exert their toxic effects through bioactivation associated with cytochrome P450 3A (CYP3A) and 2E1 (CYP2E1). Male standard (Wistar/ST) and type 2 diabetic model (GK/Jal) rats were kept on a powdered chow diet containing 0, 100, 500 mg/kg/rat of TRZ. Three weeks later, the rats were either sacrificed for an in vitro metabolism study or challenged with 0.50 g/kg CCl(4) p.o. or 0.75 g/kg APAP i.p.TRZ at 100 and 500 mg/kg/rat increased the CYP3A level as well as the testosterone 6beta-hydroxylation activities in liver microsomes, but did not affect CYP2E1. TRZ also enhanced APAP hepatotoxicity, as evidenced by significantly increased levels of alanine aminotransferase, aspartate aminotransferase and alpha-glutathione S-transferase in the plasma of rats, and by significantly low hepatic glutathione concentration. Our study demonstrated that high doses of TRZ can enhance hepatotoxicity of APAP in Wistar/ST and GK/Jal by inducing hepatic CYP3A.
- Published
- 2002
- Full Text
- View/download PDF